Search

everythinglearnresearchcommunity

for

Search:↓

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The research identified various cell types in mouse and human teeth, which could help in developing dental regenerative treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

New treatments targeting T-cell pathways are needed for better alopecia areata management.